-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation: Poster III

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Abdulmohsen M Alruwetei, Msc1,2*, Hernan Carol, PhD1*, Rosemary Sutton, PhD1*, Glenn M Marshall, MBBS, MD, FRACP1,3 and Richard B Lock, PhD1

1Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia
2College of Applied Medical Science,Medical laboratory, Qassim University, Qassim, Saudi Arabia
3Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia

Weili Sun, MD, PhD1, Jemily Malvar, MS2*, Richard Sposto, PhD3*, Anupam Verma, MD4, Jennifer J. Wilkes, MD5, Robyn M. Dennis, MD6*, Kenneth Matthew Heym, MD7*, Elena Eckroth, CCRC2*, Jeannette Vandergiesse, BA, CCRP2*, Paul S. Gaynon, MD1, Alan S. Wayne, MD1 and James A. Whitlock, MD8

1Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA
2Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA
3Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, Los Angeles, CA
4Pediatric Hematology Oncology, Primary Children's Hospital, University of Utah, Salt Lake City, UT
5Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, PA
6Nationwide Children's Hospital, Columbus, OH
7Cook Children's Hospital, Ft Worth, TX
8Hospital for Sick Children, Toronto, ON, Canada

Manju Sengar, MD, DM1, Murari Gurjar2*, Anand Patil2*, Vikram Gota2*, Hasmukh Jain, MD, DM3*, Hari Menon, MD, DM4 and Uma Dangi3*

1Hemato-Oncology Disease Management Group, Tata Memorial Hospital, Mumbai, India
2ACTREC, Tata Memorial Centre, Navi Mumbai, India
3Tata Memorial Centre, Mumbai, India
4Department of Medical & Pediatric Oncology, Tata Memorial Hospital, Mumbai, India

Vamsi K Kota, MD1, Amanda Redden Hathaway, MD2, Bijal D. Shah, MD3, Deniz Peker, MD4*, Ling Zhang, MD5, David L. Jaye, MD6, Martha Arellano, MD1, H Jean Khoury1, Anand P Jillella, MD1, Elliott F. Winton, MD1, Leonard T Heffner Jr., MD1 and Uma Borate, MD2

1Winship Cancer Institute of Emory University, Atlanta, GA
2University of Alabama at Birmingham, Birmingham, AL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL
4Pathology, University of Alabama-Birmingham, Birmingham, AL
5Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
6Department of Pathology and Laboratory Medicine, Winship Cancer Institute of Emory University, Atlanta, GA

Stephanie Nicole Shishido, PhD1*, EunJi Gang, MD PhD2*, Ruth Xu3*, Hye Na Kim2*, Yann Duchartre, PhD2*, Steven D. Mittelman, MD PhD4*, Hisham Abdel-Azim, MD1, Matthew J Oberley, MD PhD5*, Nora Heisterkamp, PhD1* and Yong-Mi Kim, MD PhD MPH1

1Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA
2Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles
3Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles
4Division of Endocrinology, Los Angeles, CA
5Department of Pediatrics, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles

Tobias Feuchtinger, MD1, Judith Feucht, MD2*, Simone Kayser3*, David Gorodezki3*, Michaela Döring, MD2*, Franziska Blaeschke, MD3*, Hans Bösmüller, MD4*, Leticia Quintanilla-Fend, Prof. Dr.4*, Patrick Schlegel, MD3*, Martin Ebinger3*, Peter J. Lang, MD5 and Rupert Handgretinger, MD6

1Ludwig Maximilians University, Dr. von Hauner University Children's Hospital, Munich, Germany
2Department of General Paediatrics, Oncology/Haematology, University Children's Hospital, Tuebingen, Germany
3University Children's Hospital, Tuebingen, Germany
4Eberhard Karls University, Institute of Pathology, Tuebingen, Germany
5Dept. of Hematology/Oncology, Children's University Hospital, Tubingen, Germany
6Hematology & Oncology, Children's University Hospital, Tuebingen, Germany

Andrew E. Place, MD, PhD1, Yana Pikman, MD1, Kristen Stevenson, MS2*, Marian H. Harris, MD, PhD3*, Todd M. Cooper, DO4, Lia Gore, M.D.5, Nobuko Hijiya, MD6, Mignon L. Loh, MD7, Melinda Pauly, MD8*, Maria Luisa Sulis, MD9*, Donna S Neuberg, ScD2, Kimberly Stegmaier, MD1, Stephen E. Sallan, MD1 and Lewis B. Silverman, MD1

1Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA
2Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
3Department of Pathology, Boston Children's Hospital, Boston, MA
4Department of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA
5Pediatrics, Section of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado Denver, Aurora, CO
6Department of Hematology, Oncology, and Stem Cell Transplantation, Ann & Robert H. Lurie Children’s Hospital/Northwestern University Feinberg School of Medicine, Chicago, IL
7Department of Pediatrics, Benioff Children’s Hospital, University of California at San Francisco, San Francisco, CA
8Department of Pediatrics, Children’s Healthcare of Atlanta/Emory University School of Medicine, Atlanta, GA
9Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Columbia University, New York, NY

Michelle L. Churchman, PhD1*, Luke Jones, BSc(Hons)2*, Kathryn Evans, BSc(Hons)2*, Jennifer Richmond, BSc(Hons)2*, Irina M Shapiro, PhD3*, Jonathan A. Pachter, PhD3*, David T. Weaver, PhD3, Peter J Houghton, PhD4*, Malcolm A. Smith, MD, PhD5, Richard B Lock, PhD2 and Charles G. Mullighan, MBBS, MSc, MD1

1Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
2Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia
3Verastem, Inc., Needham, MA
4Greehey Children's Cancer Research Institute, University of Texas Health Science Center San Antonio, San Antonio, TX
5Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD

Ben Christopher Ede, Bsc1*, Paraskevi Diamanti, BSc, PhD2*, Charlotte V. Cox, BSc3* and Allison Blair, PhD, BSc4,5

1School of Cellular Molecular Medicine, University of Bristol, Bristol, United Kingdom
2NHS Blood and Transplant, Bristol Institute for Transfusion Sciences, Bristol, England
3NHS Blood & Transplant, Bristol Institute for Transfusion Sciences, Bristol, United Kingdom
4School of Cellular & Molecular Medicine, University of Bristol, Bristol, United Kingdom
5Bristol Institute for Transfusion Sciences, NHS Blood & Transplant, Bristol, United Kingdom

Laurens T Van Der Meer, PhD1*, Samantha YA Terry, PhD2,3*, Dorette van Ingen Schenau, MSc1*, Kiki Andree, MSc1*, Gerben M Franssen, BSc2*, Debbie Roeleveld, MSc1*, Bart Metselaar, PhD4*, Thomas Reinheckel, PhD5*, Peter M Hoogerbrugge, MD, PhD6, Otto C Boerman, PhD2* and Frank N van Leeuwen, PhD1

1Laboratory of Pediatric Oncology, Radboud university medical center, Nijmegen, Netherlands
2Department of Radiology and Nuclear Medicine, Radboud university medical center, Nijmegen, Netherlands
3Division of Imaging Sciences and Bioengineering, King’s College London, London, United Kingdom
4Enceladus Pharmaceuticals, Naarden, Netherlands
5Institute for Molecular Medicine and Cell Research, Freiburg University Medical Center, Freiburg, Germany
6Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands

Susan R. Rheingold, MD1,2, Lanyi Nora Chen, BS3*, Shannon L Maude, MD, PhD1,2, Richard Aplenc, MD, PhD1,2, Christine Barker, BS1*, David M. Barrett, MD, PhD1,4*, Colleen Callahan, MSN1*, Katherine Cebry1*, Irina Kulikovskaya, PhD5*, Simon F. Lacey, PhD, BS6*, Bruce L. Levine, PhD7,8, Jan J. Melenhorst, PhD7*, Pamela A Shaw, PhD9*, Anna Sparrow1*, David T Teachey, MD1,2, Mark Duckworth, BS1*, Carl H. June, MD6,10,11 and Stephan A. Grupp, MD, PhD1,2

1Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
2Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
3Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Department of Pediatrics, University of Pennsylvania, Philadelphia, PA
5Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
6Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
7Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
8Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
9Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA
10Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
11Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

David Simon Kliman, MBBS*, Michael J Barnett, BMBS, FRCPC, FRCP, FRCPath, Raewyn Broady, MBChB, FRACP, Donna L. Forrest, MD, FRCPC, Alina S. Gerrie, MD, MPH, FRCPC, Donna E. Hogge, MD, PhD, FRCPC, Stephen H. Nantel, MD, FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Thomas J. Nevill, MD, FRCPC, Maryse M Power, MB, MRCPI, FRCPath, Kevin Song, MD, FRCPC, Heather J. Sutherland, MD, PhD, FRCPC, Cynthia L. Toze, MD, MHSc, FRCPC and Yasser Abou Mourad, MD, FRCPC

Division of Hematology and Leukemia/BMT Program of BC, University of British Columbia, Vancouver, BC, Canada

Musa Yilmaz, MD1*, Hagop M. Kantarjian, MD2, Farhad Ravandi, MD2, Jeffrey L. Jorgensen, MD, PhD3, Sa Wang, MD4*, Guillermo Garcia-Manero, MD5, Jorge E. Cortes, MD6, Koji Sasaki, MD2, Courtney DiNardo, MD2, Tapan Kadia, MD2, Jane Autry, RN7*, Rebecca Garris2* and Elias Jabbour2

1Department of Hematology & Oncology, Baylor College of Medicine, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
6Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston

Hiroyoshi Takahashi, MD1,2*, Jun Inoue, PhD1*, Kimiyoshi Sakaguchi, MD3*, Masatoshi Takagi, MD, PhD4, Shuki Mizutani, MD, PhD4* and Johji Inazawa, MD, PhD1*

1Department of Molecular Cytogenetics, Tokyo Medical and Dental University, Bunkyo-ku, Japan
2Hamamatsu University School of Medicine, Hamamatsu, Japan
3Department of Pediatrics, Hamamatsu University school of Medicine, Hamamatsu, Japan
4Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Bunkyo-ku, Japan

Cameron J Turtle, MBBS, PhD1,2, Laila-Aicha Hanafi, PhD1*, Carolina Berger, MD1,2, Daniel Sommermeyer, PhD1*, Barbara Pender, MS1*, Emily M Robinson, BS1*, Katherine Melville1*, Tanya M Budiarto, BSc1*, Natalia N Steevens1*, Colette Chaney, RN1*, Sindhu Cherian, MD3, Brent L Wood, MD, PhD1,3, Lorinda Soma, MD3*, Xueyan Chen, MD, PhD,3*, Shelly Heimfeld, PhD1, Michael C Jensen, MD1,4,5*, Stanley R. Riddell, MD1,2* and David G Maloney, MD, PhD1,6

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Department of Medicine, University of Washington, Seattle, WA
3Department of Laboratory Medicine, University of Washington, Seattle, WA
4Department of Pediatrics, University of Washington, Seattle, WA
5Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA
6Division of Medical Oncology, University of Washington, Seattle, WA

Lujia Dong, M.D.1,2, Lung-Ji Chang, PhD3,4, Zhiyong Gao, MD1*, Dao-Pei Lu, MD5, Jian-Ping Zhang, MD5*, Jing-Bo Wang, MD6*, Le-Ping Zhang, MD7*, Yu-Hong Chen, MD8*, Hu-Yong Zheng, MD9*, Ting Liu10, Ting Niu, MD, PhD10, He Huang, MD, PhD11, Rong Liu, MD12*, Heng-Xiang Wang, MD13*, Li Gao, MD14*, Tong-Hua Yang, MD15* and Xun Lai, MD15*

1BMT Center, Fu Dan University, Shanghai Dao-Pei Hospital, Shanghai, China
2America Yuva Biomed, Beijing, China
3Department of Molecular Genetics and Microbiology, University of Florida, Gainesville, FL
4Shenzhen Genoimmune Medical Institute (GIMI), Shenzhen, China
5Ludaopei Hematology Oncology Center, Beijing, China
6Department of Hematology, Beijing Aerospace General Hospital, Beijing, China
7Department of Pediatric Hematology, Peking University, People’s Hospital, Beijing, China
8Institute of Hematology, BMT Center, Peking University, People’s Hospita, Beijing, China
9Hematology Oncology Center, Beijing Children’s Hospital, Capital Medical University, Beijing, China
10Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
11Bone Marrow Transplantation Center, the First Affiliated Hospital of Zhejiang University, Hangzhou, China
12Department of Hematology, Capital Institute of Pediatrics, Beijing, China
13Department of Hematology, Air Force General Hospital, PLA, Beijing, China
14Departmen of Hematology, Xinqiao Hospital, Third Military Medical University, Chongqing, China
15Department of Hematology, First People’s Hospital of Yunnan Province, Kunming, China

*signifies non-member of ASH